Abstract
Epigenetic inactivation of tumor suppressor genes caused by hypermethylation of the promoter area is as characteristic of the tumor process as genetic disorders, serving as an alternative mechanism of the function loss by the tumor suppressor genes. An analysis of the promoter area of RARв2 gene-suppressors has been performed in the normal condition and in breast cancer by methyl-sensitive polymerase chain reaction. Methylation of CpG-dinucleotides in the RARв2 gene promoter area was demonstrated. Abnormal methylation of the RARв2 gene promoter area may be used as a marker for early diagnosis and monitoring of the treatment efficacy in patients with the breast cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Global Journal of Medical and Pharmaceutical Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
